- Telehealth Visits
Alison Reed, MD
Pediatrics • Pediatric Endocrinology- Telehealth Visits
Alison Reed, MD
Pediatrics • Pediatric Endocrinology- Telehealth Visits
On this page
About me
Dr. Alison Reed is a pediatric endocrinologist who cares for children who have diabetes or other disorders of the endocrine system (glands that produce and release hormones involved in regulating many body processes). She is involved in medical education and has a professional interest in addressing the causes of diabetes-related health care disparities.
Reed earned her medical degree at the University of Miami Miller School of Medicine. At UCSF, she completed a residency in pediatrics, an advanced training program in clinical research and a fellowship in pediatric endocrinology. She joined the UCSF faculty in 2013.
Reed is a member of the Endocrine Society, Pediatric Endocrine Society and American Diabetes Association.
In her free time, Reed enjoys spending time with her husband and their two children. Her favorite activities include hiking, camping, traveling and listening to live music.
Education
Board Certification
- Pediatric Endocrinology, American Board of Pediatrics
- Pediatrics, American Board of Pediatrics
Fellowship
- Pediatric Endocrinology, UCSF Medical Center House Staff
Residency
- Pediatrics, UCSF Medical Center House Staff
Internship
- Pediatrics, UCSF Medical Center House Staff
School
- MD, University of Miami School of Medicine - Coral Gables
Academic Title
- Health Sciences Clinical Professor
Care Keywords
Services
- Pediatrics
- Pediatric Endocrinology
Locations
Provider Research Listing
Browse clinical trials and publications by this provider
Publications
Please check with your health insurance plan regarding coverage for this type of care. Not all providers at UCSF Health are covered by every insurance plan.
For informational purposes only, a link to the federal Centers for Medicare and Medicaid Services (CMS) Open Payments web page is provided here.
The federal Physician Payments Sunshine Act requires that detailed information about payment and other payments of value worth over ten dollars ($10) from manufacturers of drugs, medical devices, and biologics to physicians and teaching hospitals be made available to the public.